HIPAA Alert: Potential Data Breach Learn More

Search
Close this search box.

Transplant

Transplant

We’re here for you. Call us at 844-346-7222 or

find a clinical trial

If you have any questions or are interested in participating in one of our Clinical Trials, please take note of the associated protocol number and contact our team at (201) 518-3587, or email us at email.

26 Clinical Trials
Transplant NA Accepting Patients
nct/study# NCT03147742 / INCB18424-MA-GD-301

An Open-Label, Expanded Access Program of Ruxolitinib for the Treatment of Graft-Versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplant

Learn More
Transplant NA Accepting Patients
nct/study# NCT02766465 / 1503

A Study to Compare Hematopoetic Cell (Bone Marrow) Transplantation to Standard Care in Adolescents and Young Adults with Severe Sickle Cell Disease

Learn More
Transplant NA Accepting Patients
nct/study# NCT02322320 / 0702-LTF

Continued, Long-Term Follow-Up and Lenalidomide Maintenance Therapy for Patients Who Have Enrolled on BMT CTN 0702 BMT CTN 0702 Long-Term Follow-Up

Learn More
Transplant NA Accepting Patients
nct/study# NCT01166009 / NMDP-HSCT-DATABASE

A Research Database for Hematopoietic Stem Cell Transplantation and Marrow Toxic Injuries

Learn More
Transplant NA Accepting Patients
nct/study# NA / PRO00001762

Analysis of Immune Repertoire in Patients undergoing Extracorporeal Photopheresis for the Treatment of Chronic GVHD

Learn More
Transplant NA Accepting Patients
nct/study# NA / PRO00005979

Retrospective Review of Viral Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation

Learn More

We are here for you

For more information or to schedule an appointment, call (844) 346-7222. You can also schedule an appointment by calling the RCCA location nearest you.

Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.